More Truth About Vaccine-Induced Myocarditis
Myocarditis Series - Part 3
On May 12 of last year, school teacher Emily Jo took her 14-year-old son Aiden to get his first Pfizer vaccine dose. The public health authorities and her son’s paediatrician unanimously recommended vaccination, prompting her decision. She knew that mRNA shots caused some number of adverse events, like all vaccines, but was re-assured by the Centers for Disease Control and Prevention (CDC) and White House’s public recommendation.
“The talk amongst the mainstream medical community was that vaccine myocarditis was mild and that this was very rare,” she told me.
At that time, despite concerning heart inflammation reports from Israel, the CDC publicly claimed to have found no signal for myocarditis after “intentionally” investigating over 200 million administered doses.
Moreover, Emily Jo was never warned of the myocarditis risk or informed about the risk-benefit profile.
“When I took Aiden to get his vaccines at the drive-through vaccination site, there was no warning about myocarditis. We were not counselled about any side effects to be aware of,” she said.
In the name of public safety, scientific innovation, and personal health, Emily Jo sent out a celebratory tweet proclaiming she and her family are “so thankful” their teenage son was able to get vaccinated.
However, her pride and relief turned out to be quite short-lived. Two days after her son’s second vaccine dose, which he got a month after his first, he ended up in the hospital after complaining about intense chest pain. He was moved to a room on the acute cardiac floor where he was found to have elevated troponin levels - a key sign of heart damage - and an abnormal electrocardiogram. Every doctor Emily Jo spoke to at the paediatric hospital Children’s Healthcare of Atlanta confirmed her son had vaccine-induced myocarditis.
Given her son’s dire condition, Emily worried Aiden might die or suffer from a catastrophic injury. Thankfully, after four distressful days at the hospital, Aiden’s troponin levels returned to baseline and he was discharged. However, this didn’t mean he could return to his normal life. Aiden was unable to do physical activity for six months.
“I had no idea how life altering ‘mild’ myocarditis actually is. I have a very hard time with the label ‘mild’ for anything that requires hospitalisation and months of inactivity,” Emily Jo said.
The most serious concern with Aiden’s vaccine injury isn’t the harrowing experience itself, but the frequency at which it occurs. Virtually any substance or medication will produce a diverse range of reactions across the human population. As Sam Harris has correctly noted, if you administer peanuts to everyone, there will be some number of fatalities and cases of anaphylaxis.
The rare incidence of life-threatening anomalies doesn’t mean that peanuts produce a net harm or should be banned altogether. Tragic interactions with any kind of externality are often exaggerated and exploited to justify irrational ideological agendas. For example, officer Derek Chauvin’s treatment of George Floyd paved the way for ‘Abolish the Police’ initiatives.
In the case of COVID-19 vaccines causing myocarditis, we aren’t dealing with statistically insignificant ratios of one in a million or even one in ten thousand. The most robust data we have — according to Dr. Tracy Beth Hoeg from the Florida Health department and Dr. Marty Makary of Johns Hopkins University — is from Dr. Katie Sharff and colleagues, who analysed a wide database from Kaiser Permanente and investigated cases that weren’t explicitly labeled as vaccine myocarditis.
In her comprehensive search, Sharff found a 1 in 1,862 rate of myocarditis after the second dose in young men ages 18 to 24. For boys ages 12 to 17, the rate was 1 in 2,650. Countries with active surveillance monitoring of medical data — such as Hong Kong — show virtually identical figures.
The risk of vaccine-induced myocarditis remains highly elevated for men up to the age of 40. Cases such as Aiden’s have prompted many honest brokers in the public health community to reflect on the CDC’s top-down vaccine recommendations. Dr. Anish Koka — a cardiologist with his own clinic in Philadelphia — believes medical experts should have been “more careful about recommending this to low-risk patients from the very outset.”
As he explained to me over email, “Clinical myocarditis is never mild — a recent paper of 12–29-year-olds found 25% of myocarditis patients end up in the ICU, and 1 patient needed ECMO (a modified heart lung machine) to stay alive.”
“The long term impacts of the persistent scars that are apparent in follow-up on cardiac MRI are also unknown,” he added.
Koka believes it was “apparent by April there was a real safety signal,” and he questions why public health authorities “didn’t make decisions starting then to at least inform the public about this potential side effect at that point. ”
“Clinical myocarditis is never mild — a recent paper of 12–29-year-olds found 25% of myocarditis patients end up in the ICU, and 1 patient needed ECMO (a modified heart lung machine) to stay alive.”
Instead of mitigating risks by further spacing vaccine doses, recommending Pfizer over Moderna, and being honest about near-zero risks of severe outcomes in younger, healthy groups, Big Pharma in collusion with the government seemingly opted for universal decrees.
Looking back on the CDC and Food and Drug Administration’s (FDA) possible negligence and recklessness, Khoka stated the harm perpetrated was “unconscionable.”
More and more medical professionals are now speaking out on the strong likelihood that vaccine-induced myocarditis seems to occur at a rate that far exceeds deaths and hospitalisations in healthy, naturally immunised men under 40.
Medicine professor Marty Makary at Johns Hopkins recently wrote in a tweet:
“Last y[ea]r, the NEJM described a 22-yr-old that died from vax-induced myocarditis & I’ve heard of many more cases. I have never heard of a young healthy person with nat[ural] immunity dying from Covid. Our gov’t doctors have not been honest about the risks:benefit in young healthy people.”
I had been frankly hesitant to make such a statement since it isn’t scientifically rigorous, but since this topic is becoming less taboo, I will say it now: without deliberately seeking, I have heard of several vaccine myocarditis cases in healthy young people but have heard of zero hospitalisations and deaths from Covid.
This observation is in line with the data. According to UK data before Omicron — when the virus was deadlier — the COVID-19 death rate was just over 0.001 percent in unvaccinated 30-year-olds.
For unvaccinated people in their 20s, the risk is more like 0.0001 percent. Hospitalisation figures (from, not with COVID-19) are similarly infinitesimally low. Compare that with a vaccine myocarditis risk of 0.05 percent in young men.
In light of the FDA and CDC’s outrageous push to vaccinate everyone with the new “bivalent” booster despite “unknown” myocarditis risks, hopefully more people will wake up and re-evaluate their blind faith in institutions who have far abandoned their ostensible mission of keeping us safe and healthy.
This is the third article in our series on Myocarditis. Part 1 and part 2 from the series on Myocarditis by this author are also available to read.